Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,851 public trials 1,786 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

NCT07405801

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Avera Cancer Institute - Marshall Marshall, Minnesota, United States
  • Avera Cancer Institute - Aberdeen Aberdeen, South Dakota, United States
  • Avera Cancer Institute - Mitchell Mitchell, South Dakota, United States
  • Avera Cancer Institute - Pierre, SD Pierre, South Dakota, United States
View all 58 locations
View Trial Details
Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

NCT07173751

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University Of California - San Diego Moores Cancer Center La Jolla, California, United States
  • Cedar Sinai - Samuel Oschin Cancer Center Los Angeles, California, United States
  • Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center Palo Alto, California, United States
View all 181 locations
View Trial Details
Recruiting

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

NCT05307705

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Stanford University Hospital Stanford, California, United States
View all 50 locations
View Trial Details
Recruiting

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

NCT07100106

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCSF Helen Diller Family CCC San Francisco, California, United States
View all 64 locations
View Trial Details
Recruiting

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

NCT07647328

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site Marietta, Georgia, United States
  • Research Site Evanston, Illinois, United States
View all 89 locations
View Trial Details
Recruiting

A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

NCT07347600

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Breast Cancer, +5 more
Locations
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Gansu Provincial Maternal and Child Health Hospital (Gansu Provincial Hospital of Traditional Chinese Medicine) Lanzhou, Gansu, China
  • The First Hospital of Jilin University Changchun, Jilin, China
  • Wenzhou Medical University Affiliated Second Hospital Wenzhou, Zhejiang, China
View all 30 locations
View Trial Details
Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations
  • City of Hope Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
View all 90 locations
View Trial Details
Recruiting

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

NCT06400472

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +42 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • NYU Langone Health - Long Island Mineola, New York, United States
View all 24 locations
View Trial Details

Related conditions